Covered recipient · General Payments record
DAVID W RAY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2025
$3,137.37
- Reported across 218 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $310.14 | 17 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $80.19 | 5 |
| Xeris Pharmaceuticals, Inc. | $42.40 | 2 |
| Lilly USA, LLC | $32.58 | 2 |
| Novo Nordisk AS | $31.35 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $29.21 | 1 |
| DEXCOM, INC. | $20.79 | 1 |
| Exact Sciences Corporation | $19.38 | 1 |
| ABBVIE INC. | $19.06 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.19 | 1 |
| Kowa Pharmaceuticals America, Inc. | $16.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.06 | 11/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203792605 | CMS |
| Amgen Inc. | $14.86 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227153893 | CMS |
| Amgen Inc. | $14.38 | 03/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227153891 | CMS |
| Amgen Inc. | $18.80 | 07/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228592995 | CMS |
| Amgen Inc. | $13.66 | 07/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227153889 | CMS |
| Amgen Inc. | $18.49 | 10/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228592993 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $18.19 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225730375 | CMS |
| Boston Scientific Corporation | $29.21 | 01/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181234690 | CMS |
| Dexcom, Inc. | $20.79 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250481324 | CMS |
| Exact Sciences Corporation | $19.38 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235440625 | CMS |
| Kowa Pharmaceuticals America, Inc. | $16.99 | 11/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243114264 | CMS |
| Lilly USA, LLC | $18.09 | 01/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186606596 | CMS |
| Lilly USA, LLC | $14.49 | 10/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186618538 | CMS |
| Novo Nordisk Inc | $15.96 | 02/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188323274 | CMS |
| Novo Nordisk Inc | $15.39 | 10/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188251534 | CMS |
| Xeris Pharmaceuticals, Inc. | $21.12 | 05/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250154608 | CMS |
| Xeris Pharmaceuticals, Inc. | $21.28 | 08/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250154610 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.